Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376501 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
A NA study, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05376501 is a NA study that has completed, run by LycoRed. The registered enrollment target is 60 participants.
The verdict
NCT05376501, a NA study, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Astaxanthin is recognized as a bioactive compound with potential benefits for human health. This study aims to evaluate a specific nutritional supplement impact on markers of oxidative stress, inflammation, lipid levels, blood flow, visual skin markers, measures of longevity, mood and skin condition.
Interventions
- DIETARY_SUPPLEMENT Astaxanthin
- OTHER Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2022-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05376501
The ClinicalTrials.gov registry entry for NCT05376501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LycoRed, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Astaxanthin is the first listed.
NCT05376501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05376501 about?
NCT05376501 is a clinical study titled "A Study to Evaluate the Effect of Astaxanthin in Healthy Participants". Astaxanthin is recognized as a bioactive compound with potential benefits for human health. This study aims to evaluate a specific nutritional supplement impact on markers of oxidative stress, inflammation, lipid levels, blood flow, visual skin markers, measures of longevity, mood and skin condition...
What is the current status of trial NCT05376501?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-08. Estimated completion is 2022-10-15.
What interventions are being tested in trial NCT05376501?
The interventions under investigation include: Astaxanthin (DIETARY_SUPPLEMENT), Placebo (OTHER).
Who is sponsoring clinical trial NCT05376501?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.